Maravai Lifesciences Holdings (MRVI) Net Margin Growth (1y) (2021 - 2026)

Maravai Lifesciences Holdings (MRVI) Net Margin Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,491.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,120.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -653.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 447.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Maravai Lifesciences Holdings 1.03 Bn 1.02 Bn 33.70 Mn 10,313.00

Historic Data

Download Data
DateValue
Mar 31, 2026 10,313.00
Dec 31, 2025 -4,492.00
Sep 30, 2025 14,161.00
Jun 30, 2025 -12,081.00
Mar 31, 2025 -7,747.00
Dec 31, 2024 6,689.00
Sep 30, 2024 -22,726.00
Jun 30, 2024 -920.00
Mar 31, 2024 -3,363.00
Dec 31, 2023 -19,105.00
Sep 30, 2023 -7,469.00
Jun 30, 2023 -8,190.00
Mar 31, 2023 -6,182.00
Dec 31, 2022 -1,293.00
Sep 30, 2022 -1,243.00
Jun 30, 2022 281.00
Mar 31, 2022 920.00
Dec 31, 2021 4,093.00
Sep 30, 2021 2,012.00
Jun 30, 2021 5,869.00